Literature DB >> 17951406

Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.

Yi-Hsuan Hsieh1, Ih-Jen Su, Hui-Ching Wang, Jui-He Tsai, Yu-Jun Huang, Wen-Wei Chang, Ming-Derg Lai, Huan-Yaw Lei, Wenya Huang.   

Abstract

The hepatitis B virus (HBV) large surface antigen (LHBS) mutant with deletion at the pre-S(2) region accumulates in endoplasmic reticulum (ER) and is associated with HBV-induced hepatocellular carcinogenesis. In this study, we found that the pre-S(2) LHBS mutant directly interacts with the Jun activation domain-binding protein 1 (JAB1). Association of pre-S(2) LHBS with JAB1 dissociated JAB1 from the JAB1/IRE1 complex in ER. The free (active) JAB1 then translocated into cell nuclei and rendered the Cdk inhibitor p27(Kip1) to cytosolic proteasome for degradation. The pre-S(2) LHBS mutant induced hyperphosphorylation of tumor suppressor retinoblastoma (RB) via cyclin-dependent kinase 2 (Cdk2), a downstream molecule regulated by p27(Kip1). This effect is independent of the ER stress signaling pathway. The transgenic mice carrying the pre-S(2) mutant LHBS gene also exhibited Cdk2 activation, p27(Kip1) degradation, as well as RB hyperphosphorylation. The mouse hepatocytes exhibited morphologic abnormalities such as chromatin condensation, multinucleation, and dysplasia of hepatocytes. In summary, the pre-S(2) LHBS mutant causes p27(Kip1) degradation through direct interaction with JAB1. The pre-S(2) mutant LHBS is suggested to be a potential oncoprotein for HBV-related hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951406     DOI: 10.1158/1541-7786.MCR-07-0098

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  33 in total

Review 1.  Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Woei-Cherng Shyu; Long-Bin Jeng; Ih-Jen Su
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

2.  Geminiviruses subvert ubiquitination by altering CSN-mediated derubylation of SCF E3 ligase complexes and inhibit jasmonate signaling in Arabidopsis thaliana.

Authors:  Rosa Lozano-Durán; Tabata Rosas-Díaz; Giuliana Gusmaroli; Ana P Luna; Ludivine Taconnat; Xing Wang Deng; Eduardo R Bejarano
Journal:  Plant Cell       Date:  2011-03-25       Impact factor: 11.277

3.  Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.

Authors:  Pok Yeung; Danny Ka-Ho Wong; Ching-Lung Lai; James Fung; Wai-Kay Seto; Man-Fung Yuen
Journal:  J Infect Dis       Date:  2011-01-12       Impact factor: 5.226

Review 4.  Clinical relevance of hepatitis B virus variants.

Authors:  Shan Gao; Zhong-Ping Duan; Carla S Coffin
Journal:  World J Hepatol       Date:  2015-05-18

Review 5.  Hepatitis B virus large surface protein: function and fame.

Authors:  Yuri Churin; Martin Roderfeld; Elke Roeb
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

6.  Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis.

Authors:  Jye-Lin Hsu; Woei-Jer Chuang; Ih-Jen Su; Wen-Jun Gui; Yu-Ying Chang; Yun-Ping Lee; Yu-Lin Ai; David T Chuang; Wenya Huang
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

7.  A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers.

Authors:  Fan-Ching Shen; Ih-Jen Su; Han-Chieh Wu; Yi-Hsuan Hsieh; Wei-Jen Yao; Kung-Chia Young; Tsung-Chuan Chang; Hui-Chuan Hsieh; Han-Ni Tsai; Wenya Huang
Journal:  J Biomed Sci       Date:  2009-09-15       Impact factor: 8.410

8.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

9.  Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma.

Authors:  Zhi-Mei Zhao; Yan Jin; Yu Gan; Yu Zhu; Tao-Yang Chen; Jin-Bing Wang; Yan Sun; Zhi-Gang Cao; Geng-Sun Qian; Hong Tu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 10.  Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?

Authors:  Akinobu Takaki; Kazuhide Yamamoto
Journal:  World J Hepatol       Date:  2015-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.